Literature DB >> 11267664

Alternative splicing and tissue-specific transcription of human and rodent ubiquitous 5-aminolevulinate synthase (ALAS1) genes.

A G Roberts1, G H Elder.   

Abstract

The rate of haem synthesis in non-erythroid mammalian tissues is controlled by the ubiquitous isoform of 5-aminolevulinate synthase (ALAS1). In order to explore the regulation of mammalian ALAS1 genes, we have investigated the transcription of the human and rat genes. The 17 kb human gene differs from the rat gene in containing an additional untranslated exon that is alternatively spliced to produce a longer, minor mRNA transcript. Relative amounts of the two transcripts were similar in all tissues examined. Analysis of mRNA transcripts in human and rat tissues revealed tissue-specific differences in the use of transcription start sites by closely similar core promoters. In brain, initiation was from sites within and upstream from the TATA box, including an initiator-like element. In liver, initiation was TATA-driven from a single downstream site that appeared to be used exclusively for induction by drugs. Intermediate patterns were observed in other tissues and cell lines. Mutation of the TATA box did not impair transcription in transfected HeLa cells but activated upstream start sites, recapitulating the brain pattern. Our findings indicate that the conformation of the core ALAS1 promoter that directs assembly of the transcription pre-initiation complex may vary between tissues and have implications for understanding the tissue-specific regulated expression of this gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11267664     DOI: 10.1016/s0167-4781(01)00187-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.

Authors:  Dulmini P Barupala; Stephen P Dzul; Pamela Jo Riggs-Gelasco; Timothy L Stemmler
Journal:  Arch Biochem Biophys       Date:  2016-01-16       Impact factor: 4.013

Review 2.  One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans.

Authors:  Iqbal Hamza; Harry A Dailey
Journal:  Biochim Biophys Acta       Date:  2012-05-08

Review 3.  Cerebroprotective functions of HO-2.

Authors:  Helena Parfenova; Charles W Leffler
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 4.  Erythroid heme biosynthesis and its disorders.

Authors:  Harry A Dailey; Peter N Meissner
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

5.  Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease.

Authors:  Barney E Dwyer; Mark A Smith; Sandy L Richardson; George Perry; Xiongwei Zhu
Journal:  Neurosci Lett       Date:  2009-05-27       Impact factor: 3.046

Review 6.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

Review 7.  Clinically important features of porphyrin and heme metabolism and the porphyrias.

Authors:  Siddesh Besur; Wehong Hou; Paul Schmeltzer; Herbert L Bonkovsky
Journal:  Metabolites       Date:  2014-11-03

8.  Inhibition of ALAS1 activity exerts anti-tumour effects on colorectal cancer in vitro.

Authors:  Yalei Zhao; Xiaoyun Zhang; Yabin Liu; Yiping Ma; Pong Kong; Tianliang Bai; Mei Han; Binghui Li
Journal:  Saudi J Gastroenterol       Date:  2020 May-Jun       Impact factor: 2.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.